Filing Flows › Nuo Therapeutics (AURX) › How it makes money
How Nuo Therapeutics (AURX) makes money
Nuo Therapeutics (AURX) made $1.8M of revenue in the second quarter 2026 (Q2 2026). Product brought in $1.7M (96%); Aurix and Private Label Centrifuge Devices brought in $72K (4%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product | $1.7M | 95.9% | — | — |
| ↳ Aurix and Private Label Kits | $1.6M | 91.5% | — | — |
| ↳ License | $78K | 4.4% | — | +4% |
| Aurix and Private Label Centrifuge Devices | $72K | 4.1% | — | — |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $1.8M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $1.8M | +153% |
| Q1 2026 | $1.3M | +169% |
| Q4 2025 | $1.1M | +178% |
| Q3 2025 | $1.0M | +178% |
| Q2 2025 | $700K | +92% |
| Q1 2025 | $484K | +106% |
| Q4 2024 | $395K | +100% |
From Nuo Therapeutics' 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does Nuo Therapeutics make money?
Nuo Therapeutics (AURX) made $1.8M of revenue in the second quarter 2026 (Q2 2026). Product brought in $1.7M (96%); Aurix and Private Label Centrifuge Devices brought in $72K (4%).
What is Nuo Therapeutics' biggest business?
Product: $1.7M in the second quarter 2026, 96% of revenue.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.